Dysfunctional Immune-Privilege In Morbid Obesity: Implications and Effect of Gastric Bypass Surgery

被引:0
|
作者
D R Cottam
P A Schaefer
G W Shaftan
L D G Angus
机构
来源
Obesity Surgery | 2003年 / 13卷
关键词
MORBID OBESITY; CANCER; APOPTOSIS; CHRONIC INFLAMMATION; L-SELECTIN; FAS ANTIGEN; CD62L; CD95; LYMPHOCYTE; NEUTROPHIL; FLOW CYTOMETRY; IMMUNE PRIVILEGE; BARIATRIC SURGERY; GASTRIC BYPASS;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link.We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Methods: Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD 69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. Results: The percentage of CD95+T cells was significantly elevated from controls (69.4% vs 56%, P=0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P=0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P=0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P=0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. Conclusion: The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
引用
收藏
页码:49 / 57
页数:8
相关论文
共 50 条
  • [1] Dysfunctional immune-privilege in morbid obesity: Implications and effect of gastric bypass surgery
    Cottam, DR
    Schaefer, PA
    Shaftan, GW
    Angus, LDG
    OBESITY SURGERY, 2003, 13 (01) : 49 - 57
  • [2] Morbid Obesity and Gastric Bypass Surgery: Biochemical Profile
    V Silvestre
    M Ruano
    Y Domínguez
    R Castro
    MC G García-Lescun
    A Rodríguez
    A Marco
    G García-Blanch
    Obesity Surgery, 2004, 14 : 1227 - 1232
  • [3] Morbid obesity and gastric bypass surgery:: Biochemical profile
    Silvestre, V
    Ruano, M
    Domínguez, Y
    Castro, R
    García-Lescun, MCG
    Rodríguez, A
    Marco, A
    García-Blanch, G
    OBESITY SURGERY, 2004, 14 (09) : 1227 - 1232
  • [4] Gastric pouch carcinoma after gastric bypass for morbid obesity
    Trincado, MT
    del Olmo, JCM
    Castaño, JG
    Cuesta, C
    Blanco, JI
    Awad, S
    Carbajo, MA
    OBESITY SURGERY, 2005, 15 (08) : 1215 - 1217
  • [5] Gastric Pouch Carcinoma after Gastric Bypass for Morbid Obesity
    M Toledano Trincado
    J C Martin del Olmo
    J García Castaño
    C Cuesta
    J I Blanco;
    Said Awad
    M A Carbajo
    Obesity Surgery, 2005, 15 : 1215 - 1217
  • [6] LATE RESULTS OF GASTRIC BYPASS-SURGERY FOR MORBID-OBESITY
    REINHOLD, RB
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1994, 13 (04) : 326 - 331
  • [7] Modified antireflux monoanastomotic laparoscopic gastric bypass in morbid obesity surgery
    Klymenko, A., V
    Klymenko, V. M.
    Bilai, A., I
    Nikolaiev, M., V
    ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (05) : 676 - 681
  • [8] Early postoperative results of gastric bypass surgery for the treatment of morbid obesity
    Coskun, Halil
    Bostanci, Oezguer
    Dilege, Ece
    Demir, Uygar
    Yuksel, Erguen
    TURKISH JOURNAL OF SURGERY, 2006, 22 (02) : 59 - 62
  • [9] Wernicke Encephalopathy in a Patient With Gastric Bypass Surgery Due to Morbid Obesity
    Hasiloglu, Zehra Isik
    Unal, Nimet Yelda
    Deniz, Sinan
    Asik, Murat
    Albayram, Sait
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2013, 51 (01): : 21 - 23
  • [10] Laparoscopic Gastric Bypass for Morbid Obesity with Linear Gastroenterostomy
    M Korenkov
    P Goh
    N Yücel
    H Troidl
    Obesity Surgery, 2003, 13 : 360 - 363